Top Stories
-
What’s new—and what’s next—in chronic lymphocytic leukemia (CLL)? Columbia oncologist Nicole Lamanna, MD, shares updates on emerging therapies and research.
Topic
-
Source:
Columbia EngineeringA team led by Elham Azizi, PhD, has developed a new computational tool aims to identify immune responses to cellular therapy in AML treatments.
Topic
-
Aaron Viny, MD, shares his story with ALL, his gratitude to the doctors and researchers that came before him, and his commitment to advancing even better blood cancer therapies.
Topic
-
As new director of the Division of Pediatric Hematology, Oncology and Stem Cell Transplantation at CUIMC, Dr. Lewis Silverman stresses the need for collaboration in pediatric cancer.
Latest News
- September 29, 2023
Carlos Romero was diagnosed with leukemia when he was in eighth grade. With his sister as the donor for his third stem cell transplant, Carlos is now fully in remission.
Topic
- April 27, 2023
After being diagnosed in 2001 with chronic lymphocytic leukemia and again in 2018 with lung cancer, Mary Ann is now successfully managing her disease and returning to her calling as an actress.
Topic
- March 8, 2023
The new Walkers Scholar Fellowship for MDS research has been made possible by a generous gift from Nancy and Joe Walker.
- February 28, 2023
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
Topic
- December 19, 2022
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
- November 10, 2022
In the last 50 years, the main approaches for treating myelodysplastic syndromes or acute myeloid leukemia have not changed. The Kousteni lab aims to change that.
- August 10, 2022
Columbia Cancer congratulates Drs. Catherine Spina and Aaron Viny, recipients of a prestigious Clinical Scientist Development Award by the Doris Duke Charitable Foundation.
Topic
- January 19, 2022
To stop acute myeloid leukemia, targeting neighboring bone cells may be a better strategy than directly targeting the cells that drive the cancer, suggests a new study led by Stavroula Kousteni, PhD.
Topic
- September 13, 2021
Surviving cancer has driven Dr. Viny's work to uncover better, more effective cancer therapies. He joins Velocity this year to raise funds for critical cancer research and improve care.
Topic
